Sun Pharma  Vs. Divi’s Labs

Published : 7 August 2023

About Company

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs).

Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients.

CMP

Rs. 1156.85

Sun Pharma 

Rs. 3858.95

Divi’s Labs

Market Capitalization

Rs. 2,78,431 crores

Rs. 1,02,205  crores

Tata Motors

Maruti Suzuki

Net Revenue

Rs. 43,886 crores

Rs. 7768 crores

Tata Motors

Maruti Suzuki

Net Profit

Rs. 8513 crores

Rs. 1823 crores

Tata Motors

Maruti Suzuki

OPM

26.8%

30.5%

Tata Motors

Maruti Suzuki

ROE

16.6%

14.9%

Tata Motors

Maruti Suzuki

P/E

31.5

56.1

Tata Motors

Maruti Suzuki